Sponsor Details / Détails des commanditaires

Alnylam is the leading RNAi therapeutics company. We are a U.S.-based biopharmaceutical company with operations around the world. Founded in 2002 on a bold vision to turn Nobel Prize-winning science into an entirely new class of medicines, Alnylam has worked tirelessly for 20 years to turn the scientific possibility of RNAi into therapeutic reality. We believe that our efforts have the potential to improve the lives of patients worldwide who are waiting for new treatment options.

Contact: Joachim Le Garrec | This email address is being protected from spambots. You need JavaScript enabled to view it. | T: 514-949-4934

SonoVue® est un agent de contraste ultrasonore de deuxième génération; fruit de nombreuses années de recherche et développement menées au sein de Bracco. SonoVue a été approuvé en Europe en 2001 et est commercialisé dans 36 pays à travers le monde. Bracco vous invite à participer à divers webinaires : https://www.nwforums.com/courses/hypersensitivity-to-ueas-update-on-ase-recommendations-on-safety-and-echo-lab-policy-sdms

Contact: Patrice Plourde | This email address is being protected from spambots. You need JavaScript enabled to view it. | T: 514-824-5744

Chez Bristol Myers Squibb, nous travaillons chaque jour pour aider les patients.  Les patients sont au cœur de tout ce que nous faisons. Ils nous inspirent et c’est pour eux que nous venons travailler tous les jours.  Nous aspirons à être au centre d’un écosystème de soins de santé dynamique, dans lequel les centres de recherche universitaires, ainsi que les sociétés biotechnologiques et biopharmaceutiques contribuent aux avancées scientifiques continues.

At Bristol Myers Squibb, we work every day to help patients. Patients are at the center of everything we do. They inspire us. They are the reason we come to work each day. We aspire to be at the center of a vibrant healthcare ecosystem, where academic research centers, biotech and biopharma companies all contribute to continued scientific advancement.

Contact: Shawn Farrell | This email address is being protected from spambots. You need JavaScript enabled to view it. | T: 514-865-9479

As a leading global medical technology innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications, and services.

Contact: Prashant Nigam | This email address is being protected from spambots. You need JavaScript enabled to view it. | 613-668-5572

With more than 65 years of experience in delivering life-changing science, Lantheus is committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Lantheus is headquartered in Massachusetts and has offices in New Jersey, Canada and Sweden. For more information, visit www.lantheus.com.

Contact: Martin Campeau | This email address is being protected from spambots. You need JavaScript enabled to view it. | T: 647-409-6355

Sanofi is an innovative global healthcare company, driven by one purpose: chasing the miracles of science to improve people's lives.

Focusing on uncommon and underserved medical conditions such as Lysosomal storage disorders (LSDs), Sanofi's Rare Disease franchise is committed to empowering the lives of patients with rare diseases by offering sustainable, transformative healthcare options.

Contact: Mr. Mathias Buytaert | This email address is being protected from spambots. You need JavaScript enabled to view it. |  T: 647-208-1781

Download Fabry Disease brochure here.

For more than 45 years, Servier Canada has consolidated its position as a leader in cardiovascular and metabolic medicine, which has paved the way to diversification into new frontiers, including oncology. We constantly strive to provide the Canadian medical community, its patients and their families with innovative therapeutic solutions.

Contact: Toll-free: 1-800-663-0839 | Tel: (450) 978-9700 | Fax: (450) 978-0402